Gufic Biosciences gets NCLT’s nod for scheme of merger

07 Sep 2018 Evaluate

Gufic Biosciences has received an approval from the National Company Law Tribunal (NCLT) for the Scheme of Merger by absorption of Gufic Stridden Bio-Pharma with the company. The Mumbai Bench of the NCLT has on September 6, 2018, pronounced the order sanctioning of the same Scheme.

Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.

Gufic Biosciences Share Price

294.55 1.25 (0.43%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×